Expert Opinion on Investigational Drugs
Journal Title
- Expert Opinion on Investigational Drugs
ISSN
- E 1744-7658 | P 1354-3784
Listed on(Coverage)
| JCR |
2002-2019 |
| SJR |
1999-2019 |
| CiteScore |
2011-2019 |
| SCIE |
2010-2021 |
| CC |
2016-2021 |
| SCOPUS |
2017-2020 |
| MEDLINE |
2016-2021 |
| EMBASE |
2016-2020 |
Aime & Scopes
- Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.
The Editors welcome:
/// Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
/// Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
/// Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.